Ionis Enlists Bicycle To Open Up New Antisense Targets In Bounce-Back Bid

Aiming To Cross Blood Brain Barrier

 
• By Andrew McConaghie

Small-molecule drug delivery tech could help Ionis deliver its oligonucleotides where others cannot reach.

Ionis HQ
Ionis has three products on the market, but is still loss-making and needs to expand the reach of its RNA-based medicines. • Source: Ionis

More from Business

More from Scrip